Effectiveness of Walking Exercise in Improving Depression in Older Adults With Major Depressive Disorder A Pilot Study

  • STATUS
    Recruiting
  • participants needed
    30
  • sponsor
    The University of Hong Kong
Send
Updated on 5 August 2020
See if I qualify

Summary

  1. This pilot randomized controlled trial aims at investigating the effects of different intensities of aerobic walking exercise to alleviate depression in older adults with major depressive disorder. Both baseline and post-intervention measurements will be conducted at the Exercise Physiology Laboratory, Division of Kinesiology, School of Public Health, The University of Hong Kong, while the exercise intervention will be conducted outdoors in a small group setting (3-5 participants).
  2. Three-time-per-week moderate-intensity (~3.5 METs) or vigorous-intensity (~7 METs) walking exercise will be prescribed to participants in two exercise groups, while the participants in the waitlist group will receive no intervention. The intervention duration is 12 weeks.
  3. We will recruit participants from the community in HK. Interested participants will be invited for a semi-structured interview including an assessment on the Beck Depression Inventory and medical history record to confirm eligibility.

Details
Condition Major depression, Endogenous depression
Age 50years - 100years
Treatment Waitlist Control, Moderate-intensity walking exercise, Vigorous-intensity walking exercise
Clinical Study IdentifierNCT04403373
SponsorThe University of Hong Kong
Last Modified on5 August 2020

Eligibility

 Yes No Not Sure

Inclusion Criteria

Older adults aged equal or over 50 years
Ethnic Chinese
Beck Depression Inventory score over 9 points
Diagnosed with MDD and currently on pharmacological treatment for MDD

Exclusion Criteria

Incapable of participating in physical exercise with major confounding conditions which are known to affect mobility
Cannot walk without assistive device
Regular exercise habit (defined as exercise > 3 times per week and each time > 50 minutes)
Any serious somatic condition that prevents walking exercise participation (such as limb loss)
History of major diseases e.g. cancer, cardio-/cerebrovascular, neurodegenerative and renal diseases
Diagnosis of dementia/Alzheimer's disease, or currently using antidementia medication
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.